Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.87M | 275.96M | 279.51M | 298.65M | 314.74M |
| Total Receivables | 31.10M | 29.35M | 35.45M | 30.62M | 32.26M |
| Inventory | 61.08M | 51.02M | 49.29M | 53.15M | 53.84M |
| Prepaid Expenses | 9.55M | 13.16M | 10.79M | 11.51M | 12.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.00K | 19.00K | 20.00K | 300.00K | 300.00K |
| Total Current Assets | 338.64M | 369.52M | 375.05M | 394.24M | 413.40M |
|
|
|||||
| Total Current Assets | 338.64M | 369.52M | 375.05M | 394.24M | 413.40M |
| Net Property, Plant & Equipment | 67.30M | 65.22M | 65.84M | 64.71M | 66.61M |
| Long-term Investments | 317.76M | 317.76M | 317.76M | 317.76M | 317.76M |
| Goodwill | 317.76M | 317.76M | 317.76M | 317.76M | 317.76M |
| Total Other Intangibles | 13.08M | 14.10M | 15.12M | 16.14M | 17.16M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.06M | 15.76M | 10.31M | 10.31M | 10.54M |
| Total Assets | 751.85M | 782.37M | 784.08M | 803.16M | 825.47M |
|
|
|||||
| Total Accounts Payable | 19.22M | 13.61M | 20.77M | 16.36M | 15.06M |
| Total Accrued Expenses | 18.91M | 28.08M | 26.98M | 23.62M | 20.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.37M | 3.28M | 448.00K | 3.62M | 3.70M |
| Total Finance Division Other Current Liabilities | 26.30M | 20.39M | 24.64M | 19.61M | 20.14M |
| Total Other Current Liabilities | 26.30M | 20.39M | 24.64M | 19.61M | 20.14M |
| Total Current Liabilities | 68.81M | 65.36M | 72.83M | 63.21M | 59.75M |
|
|
|||||
| Total Current Liabilities | 68.81M | 65.36M | 72.83M | 63.21M | 59.75M |
| Long-Term Debt | 644.33M | 644.11M | 645.38M | 645.16M | 646.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 60.42M | 59.00M | 56.59M | 54.30M | 52.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.50M | 11.53M | 3.93M | 4.40M | 5.71M |
| Total Liabilities | 785.06M | 780.00M | 778.73M | 767.07M | 763.98M |
|
|
|||||
| Common Stock & APIC | 2.72B | 2.71B | 2.70B | 2.69B | 2.68B |
| Retained Earnings | -2.75B | -2.70B | -2.70B | -2.65B | -2.62B |
| Treasury Stock & Other | -503.00K | -147.00K | 457.00K | 415.00K | 267.00K |
| Total Common Equity | -33.21M | 2.37M | 5.35M | 36.09M | 61.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.21M | 2.37M | 5.35M | 36.09M | 61.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.21M | 2.37M | 5.35M | 36.09M | 61.49M |
|
|
|||||